India Glycols to host investor meetings in Singapore on Sep 28-29
- India Glycols Limited will hold analyst meetings in Singapore on September 28-29, 2026
- Events include a non-deal meeting and a roadshow
- Discussions limited to publicly available information with no UPSI intended
- Disclosure made under Regulation 30 of SEBI Listing Regulations

*this image is generated using AI for illustrative purposes only.
India Glycols Limited will host analyst and institutional investor meetings in Singapore on September 28 and September 29, 2026. The company disclosed the schedule under Regulation 30 of the SEBI Listing Regulations.
The interactions are scheduled as non-deal meetings and roadshows. Discussions will rely solely on publicly available information. The company stated that no unpublished price sensitive information (UPSI) is intended to be discussed during these sessions.
Meeting schedule
The following table outlines the specific dates and modes of interaction planned for the Singapore events:
| Date | Event | Mode | Location |
|---|---|---|---|
| Monday, September 28, 2026 | Non-Deal | In-Person | Singapore |
| Tuesday, September 29, 2026 | Roadshow | Not specified | Not specified |
The company noted that changes to the meeting schedule may occur due to exigencies involving participants, hosts, or the company itself. This disclosure was signed by Ankur Jain, Head (Legal) & Company Secretary, on September 22, 2026.
Historical Stock Returns for India Glycols
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +18.74% | +14.95% | -73.31% | -62.53% | -65.36% | -9.76% |
How might the specific focus of these Singapore meetings reflect India Glycols' strategy to attract foreign institutional investors in the Southeast Asian market?
What potential impact could increased visibility among international analysts have on India Glycols' valuation multiples relative to its domestic peers?
Given the strict non-deal nature of the roadshow, how will the company differentiate its narrative from competitors who may be engaging in more aggressive capital-raising activities?
































